C

Caplin Point Laboratories Ltd

PharmaceuticalsSmallcap

About the company

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 2 analysts offering recommendations for Caplin Point Laboratories Ltd

100%

Buy

0%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio27.2844.18
PB Ratio4.825.54
Dividend Yield0.35%0.51%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions